PGNY News and Press, Progyny Inc. From 08/05/21

Reports Record Second Quarter Revenue of $128.7 Million, Reflecting 99% Growth Achieving Record Sales Momentum – Demand Among Prospective Accounts Returns to Pre-COVID Levels NEW YORK, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management...

Progyny's share price grew over 100% in the trailing 12 months. CVS Pharmacy selected Progyny as the fertility and family building offering for their Health Point Solutions management program. Progyny is a good long-term buy and hold option for outperforming the S&P 500. ...

ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Our differentiated positions in the health care sector ma...

NEW YORK, July 22, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period ended June 30, 2021 after the clo...

ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Small cap growth stocks regained comparative performance ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The stock market so far this year has been a study of contrasts. On one hand, the S&P 500 index and Nasdaq Composite index have rallied to all-time highs. On the other hand, though, we’ve seen bear markets ...

(Thomas Serer/Unsplash) According to Wall Street Journal, the stock market hasn’t been this quiet since 2017. But after a chaotic year for the stock market, enjoy th...

Progyny, Inc ( NASDAQ: PGNY ) shares have advanced more than  40% since the beginning of January 2021, and the current share price stands around $59. Progyny expects adjusted EBITDA between $70 million to $75 million for the  2021 fiscal year, but even this doesn’t ...

NEW YORK, June 04, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, and Mark Liv...

Polen Capital is a global independently-owned growth equity boutique, led by an experienced team of investment professionals who are committed to preserving and growing the assets of our clients through a prudent and disciplined long-term investment approach. The Portfolio returned 2....